Collegium Pharmaceutical Inc To Acquire BioDelivery Sciences International Inc - M&A Call Transcript
Hello, and welcome to the Collegium Pharmaceutical Investor Update Conference Call and Webcast. (Operator Instructions)
As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Alex Dasalla, Head of Investor Relations and Corporate Communications. Please go ahead.
Thank you, operator. This is Alex Dasalla, Head of Investor Relations and Corporate Communications at Collegium Pharmaceutical. I'd like to welcome you all this morning to our investor call to discuss Collegium's acquisition of BioDelivery Sciences International, known as BDSI, which we announced jointly in a press release issued earlier today.
Joining me on the call are Joe Ciaffoni, our Chief Executive Officer; Colleen Tupper, our Chief Financial Officer; and Scott Dreyer, our Chief Commercial Officer. Joe and Colleen will share some prepared remarks, and then we will take your questions.
Please note that in addition to the aforementioned press release, Collegium has been
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
